Patrick Finn Horve

Patrick Finn Horve

NIH NIDDK F31 Fellow · Ph.D. Candidate, Molecular Biology · University of Oregon

I study how microbiome-derived signals drive pancreatic β-cell proliferation and maturation, with applications to cell therapies for type 1 and type 2 diabetes. Before my Ph.D., I led the validation of a prototype air sampler through commercial release with Thermo Fisher Scientific.

Seeking a postdoctoral position in academia or industry, starting 2027.

  • NIH F31 Fellowship

    Independently funded by NIDDK (F31DK141197), 2025–2027. My data also supported a funded NIH R01 and R61.

  • AerosolSense · Thermo Fisher

    Took a prototype air sampler through five Design-of-Experiments validation phases to commercial release. IP licensed; named contributor.

  • BefA and β-cell expansion

    Showed that a bacterial protein opens β-cell membranes, drives calcium flux and mitochondrial function, and expands β-cells. Read more